Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8284086 | Maturitas | 2017 | 22 Pages |
Abstract
A BOADICEA risk evaluation of 10% or more most accurately predicted BRCA1/2 status, and the inclusion of age at menarche tended to improve the performance of all algorithms. Using these tools could reduce the number of tests, but at the expense of missing a significant proportion of mutation carriers.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Natalia Teixeira, Simone Maistro, Maria Del Pilar Estevez Diz, Marian J. Mourits, Jan C. Oosterwijk, Maria Aparecida Koike Folgueira, Geertruida H. de Bock,